Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth Factor Receptor

Tumor-derived vascular endothelial growth factor (VEGF) has previously been identified as a causative factor in the disturbed differentiation of myeloid dendritic cells (DC) in advanced cancer patients. Here, we investigated the potential of vascular endothelial growth factor receptor (VEGFR) tyrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Cruijsen, H., Hoekman, K., Stam, A. G. M., van den Eertwegh, A. J. M., Kuenen, B. C., Scheper, R. J., Giaccone, G., de Gruijl, T. D.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246026/
https://www.ncbi.nlm.nih.gov/pubmed/18320010
http://dx.doi.org/10.1155/2007/17315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246026/
https://www.ncbi.nlm.nih.gov/pubmed/18320010
http://dx.doi.org/10.1155/2007/17315

Ejemplares similares